After Hours
$
170.33
Change
-0.73 -0.43%
Volume
Volume 92,336
Feb 7, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 170.27
$ 171.06
Change
+0.79 +0.46%
Day low
Day high
$167.03
$171.87

52 week low
52 week high
$115.03
$217.25

Market cap
$65.41B
Average volume
5.19M
P/E ratio
6.19
Rev. per Employee
$7.86M
EPS
27.65
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MRNA
-
Moderna Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Catalent Stock Surges on Report of Danaher Interest
- Callum Keown
-
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.
- Andrew Bary
-
Moderna Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Regeneron's Earnings Beat Forecasts, With No Sales of Covid-19 Treatment
- Karishma Vanjani
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
FDA Advisers Recommend Replacing All Covid Vaccines With Bivalent Version
- Josh Nathan-Kazis
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Tuesday, still outperforms market
- MarketWatch Automation
- Loading more headlines...
Other News on MRNA
-
Top 5 4th Quarter Trades of Lipe & Dalton
- GuruFocus.com
-
Top 5 4th Quarter Trades of REIK & CO., LLC
- GuruFocus.com
-
How Biden Officials Bungled a Better Vaccine
- Allysia Finley
-
FDA Advisers Back Annual Covid-19 Boosters With Reservations About Rollout
- Liz Essley Whyte
-
Top 5 4th Quarter Trades of ARS Investment Partners, LLC
- GuruFocus.com
-
Baillie Gifford Slashes Meta, Boosts Nvidia
- GuruFocus.com
-
Johnson & Johnson Profit Falls 25%
- Peter Loftus
-
The Deceptive Campaign for Bivalent Covid Boosters
- Allysia Finley
-
Stocks Fall After Retail and Inflation Data
- Joe Wallace
-
Moderna Finds Life After Covid-19
- David Wainer
-
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them
- Jared S. Hopkins
-
J&J Slashes Production of Its Covid-19 Vaccine
- Jared S. Hopkins
-
Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Old Port Advisors Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Moderna Considers Price of $110-$130 for Covid-19 Vaccine
- Peter Loftus
-
China to Allow Rapid Tests to Confirm Covid Cases
- Rachel Liang
-
Corporate Insiders Aren’t Betting on a Market Rebound
- Jack Pitcher
- Loading more headlines...
Press Releases on MRNA
-
Learn to Evaluate Moderna Inc. Common Stock (MRNA) using the Charts
- Stock Traders Daily
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
mRNA Vaccine and Therapeutics Market Report 2023, Size, Share, Trends and Forecast to 2028
- SUPER MARKET RESEARCH
-
Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S
- PressReach.com
-
Moderna Inc. Common Stock MRNA Trading Report
- Stock Traders Daily
-
Moderna Stock Rises on Positive Business Outlook
- PressReach.com
-
Moderna to Acquire OriCiro Genomics
- ACCESSWIRE
-
Moderna Inc. Common Stock MRNA Trading Report
- Stock Traders Daily
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com